What's breaking now, across thousands of outlets.
The opportunity cost of capital is increasing, and investors need to consider the implications.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Pfizer has a history of developing treatments that generate billions in sales.
Mumbai: Passengers purchasing railway tickets or suburban season passes worth ₹2,000 or more through UPI will have to pay an additional ₹5.90 from October 15, with the charge comprising ₹5 Merchant…
Despite rising input costs, management is finding ways to improve margins.
Increasing geopolitical tensions have boosted demand for Planet Labs' products.
AbbVie's market-beating days don't seem to be over yet.
Ignite Social Enterprise Limited has revealed plans to promote locally manufactured Ghanaian products on the international market through its digital platform.
